The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In vitro, ANGPTL3-ANGPTL8 complexes inhibit LPL orders of magnitude better than either ANGPTL3 or ANGPTL8 alone.
“in vitro several studies have found that the ability of ANGPTL3-ANGPTL8 complexes to inhibit LPL is orders of magnitude better than that of either ANGPTL3 or ANGPTL8 alone (54, 115, 137, 138)”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [137]
The Results section (page unavailable) reports that ANGPTL8 alone failed to inhibit LPL in vitro, while ANGPTL3 alone and ANGPTL3–ANGPTL8 coexpression both strongly inhibited it. This supports the comparison with ANGPTL8 alone, but the paper does not show that the combination inhibits LPL orders of magnitude better than ANGPTL3 alone. (LLM, conf=0.87)
Experimental — accuracy not yet measuredOverexpression of ANGPTL8 in the absence of ANGPTL3, or vice versa, has limited ability to increase plasma triglycerides.
“overexpression of ANGPTL8 in the absence of ANGPTL3, or vice versa, has limited ability to increase plasma triglycerides (19, 115, 137)”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [137]
The Results (Fig. 1E; page unavailable) show that ANGPTL8 expression had no effect on triglycerides in mice lacking ANGPTL3. The converse is overstated: the Results say ANGPTL3 independently promoted hypertriglyceridemia, although coexpression with ANGPTL8 raised triglycerides further. (LLM, conf=0.88)
Experimental — accuracy not yet measuredMore recent studies have shown that ANGPTL3 forms a complex with ANGPTL8 and that this complex is most likely the physiologically relevant LPL inhibitor.
“As discussed below, more recent studies have shown that ANGPTL3 forms of complex with ANGPTL8 and that this complex is most likely the physiologically relevant LPL inhibitor (19, 54, 115, 137, 138).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [137]
The Abstract and Results show that ANGPTL3 and ANGPTL8 form an inhibitory complex: ANGPTL8 inhibits LPL in the presence of ANGPTL3, and coexpression raises triglycerides in mice more than ANGPTL3 alone. The paper does not establish that the complex is the predominant physiologically relevant LPL inhibitor; it also reports that ANGPTL3 inhibits LPL independently of ANGPTL8. Page numbers are unavailable in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measuredANGPTL8 does not inhibit LPL on its own.
“Although ANGPTL8 was initially reported to inhibit LPL on its own (35), later studies found that this not to be the case (115, 137, 138).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [137]
ANGPTL8 has a domain homologous to the lipase inhibitory domain of ANGPTL3 and ANGPTL4.
“ANGPTL8 has a domain homologous to the lipase inhibitory domain of ANGPTL3 and ANGPTL4 (137).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [137]
ANGPTL8 overexpression only increases plasma triglyceride levels if ANGPTL3 is present.
“ANGPTL8 overexpression only increases plasma triglyceride levels if ANGPTL3 is present (19, 137).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [137]
The LPL inhibitory domain of ANGPTL8 is incapable of inhibiting LPL when ANGPTL8 is alone, but is necessary for LPL inhibition by ANGPTL3-ANGPTL8 complexes.
“Haller et al. (137) found that this domain was incapable of inhibiting LPL when ANGPTL8 was alone, but was necessary for LPL inhibition by ANGPTL3-ANGPTL8 complexes.”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [137]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
Dewey, F. E., Gusarova, V., O’Dushlaine, C., Gottesman, O., Trejos, J., Hunt, C., Van Hout, C. V., Habegger, L., Buckler, D., Lai, K.-M. V., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510926 · Cited by 497
Self-citationKöster, A., Chao, Y. B., Mosior, M., Ford, A., Gonzalez-DeWhitt, P. A., Hale, J. E., Li, D., Qiu, Y., Fraser, C. C., Yang, D. D., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0476 · Cited by 427
ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell Expansion
Gusarova, V., Alexa, C. A., Na, E., Stevis, P. E., Xin, Y., Bonner-Weir, S., Cohen, J. C., Hobbs, H. H., Murphy, A. J., Yancopoulos, G. D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.027 · Cited by 202
Self-citation
Flagged first, then by citations
Research works printed but not linked: 11
- Romeo, 2009, Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans, J. Clin. Invest., 119, 70
- Zhang, 2012, Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels, Biochem. Biophys. Res. Commun., 424, 786, 10.1016/j.bbrc.2012.07.038 · DOI · Paper page
- Quagliarini, 2012, Atypical angiopoietin-like protein that regulates ANGPTL3, Proc. Natl. Acad. Sci. USA., 109, 19751, 10.1073/pnas.1217552109 · DOI · Paper page
- Wang, 2015, Hepatic ANGPTL3 regulates adipose tissue energy homeostasis, Proc. Natl. Acad. Sci. USA., 112, 11630, 10.1073/pnas.1515374112 · DOI · Paper page
- Yau, 2009, A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization, J. Biol. Chem., 284, 11942, 10.1074/jbc.M809802200 · DOI · Paper page
- Basu, 2011, Determination of lipoprotein lipase activity using a novel fluorescent lipase assay, J. Lipid Res., 52, 826, 10.1194/jlr.D010744 · DOI
- Fairhead, 2015, Site-specific biotinylation of purified proteins using BirA. Methods in molecular biology, 1266, 171
- Gusarova, 2015, ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys, J. Lipid Res., 56, 1308, 10.1194/jlr.M054890 · DOI · Paper page
- Gusarova, V., S. Banfi, C. A. Alexa-Braun, L. M. Shihanian, I. J. Mintah, J. S. Lee, Y. Xin, Q. Su, V. Kamat, J. C. Cohen, . ANGPTL8 blockade with a monoclonal antibody promotes triglyceride clearance, energy expenditure and weight loss in mice. Endocrinology. Epub ahead of print. February 15, 2017. · DOI
- Siddiqa, 2016, Structural characterization of ANGPTL8 (betatrophin) with its interacting partner lipoprotein lipase, Comput. Biol. Chem., 61, 210, 10.1016/j.compbiolchem.2016.01.009 · DOI
- Wang, 2013, Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis, Proc. Natl. Acad. Sci. USA., 110, 16109, 10.1073/pnas.1315292110 · DOI · Paper page
Cited by
Sorted by citations
Sandesara, P. B., Virani, S. S., Fazio, S., & Shapiro, M. D. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00184 · Cited by 608
Hepatokines and metabolism: Deciphering communication from the liver
Jensen-Cody, S. O., & Potthoff, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101138 · Cited by 252
Lipoprotein lipase and its regulators: an unfolding story
Wu, S. A., Kersten, S., & Qi, L. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.11.005 · Cited by 225
Angiopoietin-like 3 in lipoprotein metabolism
Kersten, S. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.119 · Cited by 220
Adam, R. C., Mintah, I. J., Alexa-Braun, C. A., Shihanian, L. M., Lee, J. S., Banerjee, P., Hamon, S. C., Kim, H. I., Cohen, J. C., Hobbs, H. H., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000888 · Cited by 208
Self-citationRegulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8
Sylvers-Davie, K. L., & Davies, B. S. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2021 · Cited by 154
Chait, A., & Eckel, R. H. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0203 · Cited by 128
Dijk, W., Ruppert, P. M. M., Oost, L. J., & Kersten, S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002426 · Cited by 72
Hypertriglyceridemia—causes, significance, and approaches to therapy
Santos-Baez, L. S., & Ginsberg, H. N. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00616 · Cited by 66
Helkkula, P., Kiiskinen, T., Havulinna, A. S., Karjalainen, J., Koskinen, S., Salomaa, V., Daly, M. J., Palotie, A., Surakka, I., Ripatti, S., et al. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009501 · Cited by 47
Zhang, R. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.795370 · Cited by 15
Hypertriglyceridemia: molecular and genetic landscapes
Scicchitano, P., Amati, F., Ciccone, M. M., D’Ascenzi, F., Imbalzano, E., Liga, R., Paolillo, S., Pastore, M. C., Rinaldi, A., Mattioli, A. V., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126364 · Cited by 13
Metadata
- Authors
- Haller, J. F., Mintah, I. J., Shihanian, L. M., Stevis, P., Buckler, D., Alexa-Braun, C. A., Kleiner, S., Banfi, S., Cohen, J. C., Hobbs, H. H., Yancopoulos, G. D., Murphy, A. J., Gusarova, V., & Gromada, J.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 58
- Issue
- 6
- Pages
- 1166-1173
- ISSN
- 0022-2275
- Cited by
- 199
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review